News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Shanghai Generon Initiates a Phase II Trial for Breast Cancer in the US


5/9/2012 9:25:45 AM

2012-5-9--Shanghai Generon announced that it will initiate a randomized, multi-center Phase 2 clinical trial in the US in breast cancer patients receiving myelotoxic chemotherapy. The company believes F-627 is one of the first innovative biologic drug candidates developed by a Chinese biotech company to enter global clinical development. More details…

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES